Latest News

As the Australian market faces a challenging period with ASX 200 futures indicating a continued slide, investors are closely watching economic indicators such as the upcoming minimum wage decision and first-quarter GDP figures. In this environment of cautious sentiment, discovering promising small-cap stocks that demonstrate resilience and growth potential can be particularly rewarding for those looking to navigate these uncertain times.

Those following along with The Charles Schwab Corporation ( NYSE:SCHW ) will no doubt be intrigued by the recent...

As Australian shares face a challenging outlook with the ASX 200 futures indicating a potential slide, investors are closely watching economic indicators such as the minimum wage decision and first-quarter GDP figures. In this context, penny stocks—often smaller or newer companies—remain an intriguing area for those looking to explore beyond established market players. Despite being considered an outdated term, these stocks can offer unique opportunities for growth when backed by solid...

Readers hoping to buy Information Services Group, Inc. ( NASDAQ:III ) for its dividend will need to make their move...

Investors may be wondering if Hitachi at ¥5,083 per share still offers value after a strong run, or if most of the upside is already reflected in the price. The stock has returned 0.5% over the past week, 6.0% over the past month, 0.3% year to date, 30.8% over the past year and 206.4% over three years, with a very large 5 year return that is more than 4x the starting level. Recent attention on Hitachi has focused on its position within capital goods and broader infrastructure related themes,...

Recent performance snapshot for Lionsgate Studios (LION) Lionsgate Studios (LION) has drawn investor attention after recent trading, with the stock closing at $13.86 and showing mixed short term returns alongside stronger longer term performance figures. See our latest analysis for Lionsgate Studios. While the share price slipped 3.4% over the past day and 7.3% over the past week, it still shows strong momentum overall, with a 90 day share price return of 52.6% and a 1 year total shareholder...

Crane stock snapshot and recent performance Crane (CR) gives investors exposure to engineered industrial products across aerospace and process flow markets, with shares last closing at US$182.05. The stock is up about 6% over the past month and down roughly 9% over the past 3 months. See our latest analysis for Crane. Recent trading points to fading short term momentum, with the share price down about 9.4% over three months. However, total shareholder returns of 7.1% over one year and very...

Gentherm stock snapshot after recent trading move Gentherm (THRM) has caught investor attention after a recent rebound in its share price, with the stock up 17.4% over the past month and 14.1% over the past 3 months based on provided data. See our latest analysis for Gentherm. The recent strength in Gentherm’s share price, including a 2.57% 1 day share price return and 8.67% over 7 days, comes against a mixed backdrop where the year to date share price return is down 3.39% but the 1 year...

If you have ever wondered whether NextEra Energy at around US$83.66 reflects a fair price or a stretch, this is a good moment to step back and test what the current tag might really mean for long term investors. The stock has slipped around 5.5% over the past week and about 13.7% over the past month, yet it is still up 3.4% year to date and around 21.8% over the past year, which can change how the risk and reward trade off feels right now. Recent news coverage has largely focused on the...

Siemens (XTRA:SIE) has launched Intelligence Center X, an industrial AI orchestration platform aimed at connecting people, AI agents, and factory workflows. The company has also expanded its Siemens Xcelerator ecosystem through a new partnership with U.S. additive manufacturing firm Haddy, focused on sustainable and circular production. These announcements extend Siemens' digital and AI offering across industrial automation and next generation manufacturing. For investors tracking Siemens...

Capricor Therapeutics stock reaction and recent performance snapshot Capricor Therapeutics (CAPR) has drawn investor attention after recent trading moves, with the stock closing at US$28.53, as ongoing phase 3 work on its lead Duchenne muscular dystrophy therapy continues to shape sentiment. See our latest analysis for Capricor Therapeutics. Short term, the stock has cooled after its recent phase 3 developments, with the 1 day share price return down 4.8% and the 1 month share price return...

Rayonier (NYSE:RYN) has completed its merger with PotlatchDeltic earlier than initially planned. The combined timberland REIT is targeting substantial operational synergies across its enlarged portfolio. The deal reinforces Rayonier's focus on sustainable timberland management and expands its operating footprint. For shareholders, the timing of this merger comes after a challenging few years for NYSE:RYN, with the stock down 11.7% over 3 years and 22.9% over 5 years. The current share price...

If you are wondering whether Autodesk at around US$248 a share is offering fair value or whether you are paying up for quality, this article breaks down what the current price may be implying. The stock is up 3.0% over the past week and 1.6% over the past month, but year to date it is down 13.5% and the 1 year return is a decline of 16.0%. This can change how investors think about both upside potential and risk. Recent headlines around Autodesk have focused on its role in core design...

If you are wondering whether Republic Services at around US$200.83 is still a solid deal or starting to look expensive, the key is to understand what the current price actually reflects. The stock is down 3.9% over the past week, 2.8% over the last month, 4.5% year to date, and 21.3% over the past year, although the 3 year and 5 year returns of 44.7% and 97.2% tell a different, longer term story. Recent market attention has focused on Republic Services as part of broader interest in...

The recent upgrade of Oversea-Chinese Banking (SGX:O39) by a major analyst has drawn fresh attention to the stock, as investors weigh what rising earnings confidence might imply for returns and risk. See our latest analysis for Oversea-Chinese Banking. The share price has been firming, with a 1-day share price return of 2.91% taking Oversea-Chinese Banking to SGD24.08 and adding to a 30-day share price return of 9.95%. The 1-year total shareholder return of 56.70% points to strong momentum,...

Roche Holding (SWX:ROP) is back in focus after a string of late May and early June product updates in obesity treatments and oncology, including fresh U.S. regulatory decisions and new clinical data presentations. See our latest analysis for Roche Holding. Despite the flurry of obesity and oncology updates, momentum in the shares has eased, with the 90 day share price return down 13.68% and the year to date share price return down 4.85%, even as the 1 year total shareholder return stands at...

Airbus (ENXTPA:AIR) has entered a multi-year artificial intelligence partnership with Mistral AI. The collaboration focuses on aerospace design, production automation, cybersecurity, and defense applications. The deal expands Airbus's use of AI across core functions in both civil and defense activities. For you as an investor, this move relates to how Airbus is approaching its core business in commercial aircraft, helicopters, and defense systems. AI tools could be applied across design...

The Canadian market is currently navigating a challenging landscape, with recent data indicating a technical recession due to marginal declines in growth. Despite these headwinds, investors can find potential opportunities by focusing on stocks that demonstrate strong financial fundamentals. Penny stocks, often smaller or newer companies, remain relevant for those looking for affordable investments with growth potential when backed by robust financials.

Investors may be wondering if Sherwin-Williams at around US$294.86 is a bargain or just fairly priced, especially after a choppy run for the stock. The share price is down about 4.6% over the past week, 7.3% over the past month, and 10.1% year to date, with a 16.3% decline over the last year, but a gain of 26.3% over three years and 9.8% over five years. These mixed returns have kept Sherwin-Williams on many watchlists, with investors weighing long term prospects against recent share price...

This article examines whether Kinaxis at around C$170 a share represents fair value or a potential mispricing opportunity by looking at what the current numbers suggest about the stock. Kinaxis has recently attracted attention, with the stock up 16.5% over the past week and 17.6% over the past month, while the year-to-date return is down 1.0% and the 1-year return is down 13.7%. These mixed returns sit against a longer backdrop where the stock is down 8.6% over 3 years but up 28.0% over 5...

What recent performance signals for H&R Block (HRB) H&R Block (HRB) has drawn fresh attention after a strong month, with the stock up about 27% over that period and about 26% over the past 3 months, against weaker year-to-date and 1-year returns. See our latest analysis for H&R Block. The recent 30 day share price return of 26.62% and 90 day return of 25.62% sit against a weaker year to date share price return and a 1 year total shareholder return that declined 29.73%, while the 3 and 5 year...

BNP Paribas is seeking to overturn a prior U.S. court judgment in a major legal appeal that challenges how foreign law was applied and how it could present its defense. The case has attracted amicus briefs from governments, academics, jurists, and industry groups, signaling wider implications for cross border banking and international legal practice. The outcome may influence how global banks manage legal risk in U.S. courts and how foreign law is treated in complex cross border...

Recent Performance Snapshot Allianz (XTRA:ALV) has drawn investor attention after a mixed stretch in its share performance, with the stock down over the past week and month, yet showing a gain over the past 3 months. See our latest analysis for Allianz. Despite a weaker patch in the 1 day and 1 month share price returns, Allianz’s 1 year and multi year total shareholder returns suggest longer term momentum has remained comparatively resilient. If Allianz’s recent swings have you thinking...

Wondering whether Abbott Laboratories at US$87.78 is starting to look interesting on valuation, or if the market still sees more downside risk than upside. The stock is up 0.4% over the last week but down 1.9% over the last 30 days, with year to date and 1 year returns declining 29.3% and 32.9% respectively, which puts recent moves in sharp contrast to longer term performance. These returns have kept Abbott Laboratories in focus alongside ongoing sector wide interest in healthcare companies,...